Biotage AB (publ) (BITGF)
USD 11.5
(31.13%)
USD 11.5
(31.13%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 | -36.49 Million USD | -92.02% |
| 2022 | -19 Million USD | -182.97% |
| 2021 | -6.71 Million USD | 64.88% |
| 2020 | -19.12 Million USD | -953.65% |
| 2019 | -1.81 Million USD | 76.2% |
| 2018 | -7.62 Million USD | 64.17% |
| 2017 | -21.28 Million USD | -50.33% |
| 2016 | -14.15 Million USD | 11.51% |
| 2015 | -15.99 Million USD | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 Q3 | -220 Million USD | -1147.5% |
| 2024 Q2 | 11.45 Million USD | 571.74% |
| 2024 Q1 | -2.42 Million USD | -174.56% |
| 2023 FY | 3.25 Million USD | 117.14% |
| 2023 Q3 | -8.48 Million USD | -53.15% |
| 2023 Q2 | -5.53 Million USD | 70.54% |
| 2023 Q4 | 3.25 Million USD | 138.4% |
| 2023 Q1 | -18.79 Million USD | 1.1% |
| 2022 Q2 | -6.52 Million USD | 59.31% |
| 2022 FY | -19 Million USD | -182.97% |
| 2022 Q4 | -19 Million USD | -53.53% |
| 2022 Q3 | -12.37 Million USD | -89.69% |
| 2022 Q1 | -16.03 Million USD | -138.77% |
| 2021 Q1 | -21.74 Million USD | 0.0% |
| 2021 Q4 | -6.71 Million USD | 75.71% |
| 2021 Q3 | -27.65 Million USD | -46.81% |
| 2021 Q2 | -18.83 Million USD | 13.39% |
| 2021 FY | -6.71 Million USD | 64.88% |
| 2020 FY | -19.12 Million USD | -953.65% |
| 2019 FY | -1.81 Million USD | 76.2% |
| 2018 FY | -7.62 Million USD | 64.17% |
| 2017 FY | -21.28 Million USD | -50.33% |
| 2016 FY | -14.15 Million USD | 11.51% |
| 2015 FY | -15.99 Million USD | 0.0% |
| Name | Net Debt | Net Debt Difference |
|---|---|---|
| American Medical Technologies Inc. | 479.63 Thousand USD | 7708.592% |
| Ansell Limited | -54.99 Million USD | 33.645% |
| Ansell Limited | -55.1 Million USD | 33.769% |
| BG Medicine, Inc. | - USD | Infinity% |
| BioLife Sciences Inc. | - USD | Infinity% |
| CB Scientific, Inc. | -105.1 Thousand USD | -34621.667% |
| Psykey, Inc. | 634.59 Thousand USD | 5850.641% |
| ConvaTec Group Plc | 1.2 Billion USD | 103.04% |
| ConvaTec Group Plc | 1.2 Billion USD | 103.035% |
| Encision Inc. | 1.29 Million USD | 2927.409% |
| Golden Valley Development, Inc | - USD | Infinity% |
| Hear AtLast Holdings, Inc. | 2.3 Million USD | 1680.669% |
| Innovative MedTech Inc. | 1.76 Million USD | 2167.911% |
| LifePoint, Inc. | -3.26 Million USD | -1018.043% |
| Medite Cancer Diagnostics, Inc. | 4.9 Million USD | 844.123% |
| Paradigm Medical Industries, Inc. | 2.16 Million USD | 1787.936% |
| QuantRx Biomedical Corporation | - USD | Infinity% |
| Remedent, Inc. | -43.3 Thousand USD | -84172.044% |
| Reflect Scientific, Inc. | -1.03 Million USD | -3424.864% |
| SmileDirectClub, Inc. | 778.67 Million USD | 104.687% |
| Sector 10, Inc. | 163 Thousand USD | 22488.445% |
| Shandong Weigao Group Medical Polymer Company Limited | -417.55 Million USD | 91.26% |
| SheerVision, Inc. | 57.34 Thousand USD | 63733.483% |
| United Health Products, Inc. | 660.56 Thousand USD | 5624.505% |
| Vasamed, Inc. | 22.12 Thousand USD | 165063.231% |
| Wearable Health Solutions, Inc. | 2.63 Million USD | 1486.93% |
| Yubo International Biotech Limited | 772.27 Thousand USD | 4825.386% |